>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Applied Materials (AMAT) upgraded to Outperform from Neutral at Mizuho, tgt $370
    • Bank of Montreal (BMO) upgraded to Buy from Hold at TD Securities
    • Circle Internet Group (CRCL) upgraded to Neutral from Underperform at Mizuho, tgt $77
    • Energy Fuels (UUUU) upgraded to Neutral from Sell at Roth Capital, tgt $15.50
    • Johnson & Johnson (JNJ) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $262
    • KKR (KKR) upgraded to Buy from Hold at HSBC, tgt $144
    • Korro Bio (KRRO) upgraded to Overweight from Neutral at Cantor Fitzgerald, tgt $21
    • Microchip (MCHP) upgraded to Buy from Neutral at BofA Securities, tgt $95
    • Nextpower (NXT) upgraded to Overweight from Sector Weight at KeyBanc, tgt $142
    • Texas Instruments (TXN) upgraded to Neutral from Underperform at BofA Securities, tgt $235
    • Visa (V) upgraded to Buy from Neutral at Rothschild & Co Redburn, tgt $385
  • Downgrades:
    • Array Technologies (ARRY) downgraded to Neutral from Outperform at Robert W. Baird, tgt $11
    • Banco Bilbao Vizcaya Argentaria (BBVA) downgraded to Sector Perform from Outperform at RBC Capital
    • BJ's Wholesale (BJ) downgraded to Hold from Buy at Jefferies, tgt $90
    • Brown & Brown (BRO) downgraded to Neutral from Buy at Citigroup, tgt $83
    • Capital City Bank Group (CCBG) downgraded to Market Perform from Outperform at Keefe Bruyette, tgt $45
    • Coca-Cola Femsa (KOF) downgraded to Neutral from Overweight at JPMorgan, tgt $100
    • Martin Marietta Materials (MLM) downgraded to Hold from Buy at Loop Capital, tgt $690
    • Nucor (NUE) downgraded to Neutral from Buy at UBS, tgt $183
    • PayPal (PYPL) downgraded to Sell from Neutral at Rothschild & Co Redburn, tgt $50
    • Plains All American Pipeline (PAA) downgraded to Underperform from Neutral at BofA Securities, tgt $19
    • Plains GP Holdings (PAGP) downgraded to Underperform from Neutral at BofA Securities, tgt $19
    • Portfolio Recovery Associates (PRAA) downgraded to Market Perform from Outperform at Citizens
    • Rio Tinto (RIO) downgraded to Equal Weight from Overweight at Morgan Stanley
    • Roper Technologies (ROP) downgraded to Hold from Buy at Stifel, tgt $385
    • Roper Technologies (ROP) downgraded to Perform from Outperform at Oppenheimer
    • Western Alliance Bancorporation (WAL) downgraded to Neutral from Overweight at JPMorgan, tgt $105
  • Others:
    • 4D Molecular Therapeutics (FDMT) assumed with an Overweight at Barclays, tgt $33
    • Aardvark Therapeutics (AARD) initiated with a Buy at B. Riley, tgt $32
    • Alnylam Pharmaceuticals (ALNY) assumed with an Overweight at Barclays, tgt $527
    • Altimmune (ALT) initiated with an Overweight at Barclays, tgt $20
    • Apellis Pharmaceuticals (APLS) initiated with an Equal Weight at Barclays, tgt $24
    • Ascendis Pharma (ASND) initiated with an Overweight at Barclays, tgt $342
    • BioMarin Pharmaceutical (BMRN) assumed with an Overweight at Barclays, tgt $80
    • BridgeBio Pharma (BBIO) initiated with an Overweight at Barclays, tgt $157
    • Celestica (CLS) initiated with a Buy at BofA Securities, tgt $400
    • Coinbase Global (COIN) initiated with a Neutral at Robert W. Baird, tgt $240
    • Cytokinetics (CYTK) assumed with an Overweight at Barclays, tgt $87
    • FormFactor (FORM) initiated with a Hold at Freedom Capital, tgt $64
    • Gossamer Bio (GOSS) initiated with an Overweight at Barclays, tgt $9
    • HeartFlow (HTFL) initiated with an Overweight at Wells Fargo, tgt $38
    • Insmed (INSM) initiated with an Overweight at Barclays, tgt $231
    • Ionis Pharmaceuticals (IONS) assumed with an Overweight at Barclays, tgt $95
    • Inventiva (IVA) initiated with an Overweight at Barclays, tgt $18
    • Kymera Therapeutics (KYMR) assumed with an Overweight at Barclays, tgt $133
    • Madrigal Pharmaceuticals (MDGL) initiated with an Overweight at Barclays, tgt $964
    • MBX Biosciences (MBX) initiated with an Overweight at Barclays, tgt $66
    • Moderna (MRNA) assumed with an Equal Weight at Barclays, tgt $25
    • Nano Nuclear Energy (NNE) initiated with a Buy at Texas Capital, tgt $49
    • NuScale Power (SMR) initiated with a Buy at Texas Capital, tgt $23
    • Oklo (OKLO) initiated with a Buy at Texas Capital, tgt $138
    • PTC Therapeutics (PTCT) assumed with an Overweight at Barclays, tgt $119
    • Raymond James Financial (RJF) initiated with an Overweight at Barclays, tgt $191
    • Regenxbio (RGNX) assumed with an Overweight at Barclays, tgt $37
    • Sagimet Biosciences (SGMT) initiated with an Equal Weight at Barclays, tgt $8
    • Sarepta Therapeutics (SRPT) assumed with an Equal Weight at Barclays, tgt $20
    • Shattuck Labs (STTK) initiated with an Overweight at Piper Sandler, tgt $15
    • TPG (TPG) initiated with an Overweight at Barclays, tgt $78
    • Tyra Biosciences (TYRA) initiated with an Overweight at Barclays, tgt $59
    • uniQure (QURE) initiated with an Equal Weight at Barclays, tgt $31
    • Vertex Pharmaceuticals (VRTX) assumed with an Overweight at Barclays, tgt $606